Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）

This study is using artificial intelligence (AI) to analyze CT scan images and genetic data together to better predict how esophageal cancer patients will respond to treatment and to refine how their risk is classified. The goal is to make cancer care more personalized and precise. **You may be eligible if:** - You have been diagnosed with esophageal cancer confirmed by biopsy - You have complete baseline medical data available (including ECOG score, cancer stage, and other clinical information) - A CT scan was taken before treatment started - You are willing to provide informed consent **You may NOT be eligible if:** - Your CT scan images are not clear enough for analysis - You have another primary cancer in addition to esophageal cancer - You have a severe systemic illness Talk to your doctor to see if this trial is right for you.